Scuba Doc
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Scuba Doc

Forum Replies Created

Viewing 1 reply thread
1 2 3 4
  • Replies
      • September 18, 2014 at 12:18 pm
      Scuba Doc
      Participant

      If you have no other options ( Yervoy, PD-1 etc. ) the NRAS mutation can be treated with "Mekinist" ( trametinib ) in an 'off label' prescription here in the US. We have been approved by Humana Ins. with a small co-pay. 

      • September 18, 2014 at 12:18 pm
      Scuba Doc
      Participant

      If you have no other options ( Yervoy, PD-1 etc. ) the NRAS mutation can be treated with "Mekinist" ( trametinib ) in an 'off label' prescription here in the US. We have been approved by Humana Ins. with a small co-pay. 

      • September 18, 2014 at 12:18 pm
      Scuba Doc
      Participant

      If you have no other options ( Yervoy, PD-1 etc. ) the NRAS mutation can be treated with "Mekinist" ( trametinib ) in an 'off label' prescription here in the US. We have been approved by Humana Ins. with a small co-pay. 

      • September 9, 2014 at 12:03 pm
      Scuba Doc
      Participant

      Dr. Keith Flaherty at MGH, Boston —- responds very quickly to e-mails–KFLAHERTY@mgh.harvard.edu

      • September 9, 2014 at 12:03 pm
      Scuba Doc
      Participant

      Dr. Keith Flaherty at MGH, Boston —- responds very quickly to e-mails–KFLAHERTY@mgh.harvard.edu

      • September 9, 2014 at 12:03 pm
      Scuba Doc
      Participant

      Dr. Keith Flaherty at MGH, Boston —- responds very quickly to e-mails–KFLAHERTY@mgh.harvard.edu

      • September 4, 2014 at 8:54 pm
      Scuba Doc
      Participant

      Pembrolizumab works just as well as a first line treatment — I wonder if  doctors will be able to get it 'Off Label" soon? And if insurance companies would help cover the cost?  

      • September 4, 2014 at 8:54 pm
      Scuba Doc
      Participant

      Pembrolizumab works just as well as a first line treatment — I wonder if  doctors will be able to get it 'Off Label" soon? And if insurance companies would help cover the cost?  

      • September 4, 2014 at 8:54 pm
      Scuba Doc
      Participant

      Pembrolizumab works just as well as a first line treatment — I wonder if  doctors will be able to get it 'Off Label" soon? And if insurance companies would help cover the cost?  

      • July 13, 2014 at 1:36 pm
      Scuba Doc
      Participant

      Why not just Nivolumab alone , when the early test results show an equal or better response using Nivolumab as a mono theraphy vrs.a combination of  Ipi and Nivo??

      • July 13, 2014 at 1:36 pm
      Scuba Doc
      Participant

      Why not just Nivolumab alone , when the early test results show an equal or better response using Nivolumab as a mono theraphy vrs.a combination of  Ipi and Nivo??

      • July 13, 2014 at 1:36 pm
      Scuba Doc
      Participant

      Why not just Nivolumab alone , when the early test results show an equal or better response using Nivolumab as a mono theraphy vrs.a combination of  Ipi and Nivo??

      • June 25, 2014 at 11:26 am
      Scuba Doc
      Participant

      Perhaps with all the new test results Merck will allow melanoma patients to take pembrolizumab regardless of having been previously treated with IPI. I know that some patients opted not to take the IPI for other health reasons. Allowing those patients access to pembrolizumab seem like a no brainer based on the current data.

      • June 25, 2014 at 11:26 am
      Scuba Doc
      Participant

      Perhaps with all the new test results Merck will allow melanoma patients to take pembrolizumab regardless of having been previously treated with IPI. I know that some patients opted not to take the IPI for other health reasons. Allowing those patients access to pembrolizumab seem like a no brainer based on the current data.

      • June 25, 2014 at 11:26 am
      Scuba Doc
      Participant

      Perhaps with all the new test results Merck will allow melanoma patients to take pembrolizumab regardless of having been previously treated with IPI. I know that some patients opted not to take the IPI for other health reasons. Allowing those patients access to pembrolizumab seem like a no brainer based on the current data.

Viewing 1 reply thread
1 2 3 4
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

Popular Topics